Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wild-type patients treated with biologics second-line mCRC.
| dc.contributor.author | Yildirim, Mahmut Emre | |
| dc.contributor.author | Karaca, Mustafa | |
| dc.contributor.author | Artac, Mehmet | |
| dc.contributor.author | Cicin, Irfan | |
| dc.contributor.author | Geredeli, Caglayan | |
| dc.contributor.author | Alacacioglu, Ahmet | |
| dc.contributor.author | Simsek, Eda Tanrikulu | |
| dc.date.accessioned | 2025-05-10T19:27:40Z | |
| dc.date.issued | 2022 | |
| dc.department | İstanbul Medeniyet Üniversitesi | |
| dc.description | Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) -- JUN 03-07, 2022 -- ELECTR NETWORK | |
| dc.description.abstract | [No abstract available] | |
| dc.description.sponsorship | Amer Soc Clin Oncol | |
| dc.description.sponsorship | Amgen | |
| dc.description.sponsorship | Amgen. | |
| dc.identifier.endpage | E15562 | |
| dc.identifier.issn | 0732-183X | |
| dc.identifier.issn | 1527-7755 | |
| dc.identifier.issue | 16 | |
| dc.identifier.scopusquality | Q1 | |
| dc.identifier.startpage | E15562 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14730/7031 | |
| dc.identifier.volume | 40 | |
| dc.identifier.wos | WOS:000863680303045 | |
| dc.identifier.wosquality | Q1 | |
| dc.indekslendigikaynak | Web of Science | |
| dc.language.iso | en | |
| dc.publisher | Lippincott Williams & Wilkins | |
| dc.relation.ispartof | Journal of Clinical Oncology | |
| dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.snmz | KA_WOS_20250302 | |
| dc.title | Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wild-type patients treated with biologics second-line mCRC. | |
| dc.type | Conference Object |










